New research suggests that bones may play an active role in managing blood sugar levels, revealing a complex, two-way relationship with metabolic health that could influence future treatment strategies.
Bones are often seen simply as the body’s scaffolding, but research suggests they may do more than hold us upright. According to The Indian Express, scientists and doctors are increasingly examining whether the skeleton also takes part in the way the body manages glucose, adding another layer to the familiar picture of blood sugar control. That idea rests on the fact that bone is living tissue, constantly being remodelled, and it may send signals that interact with systems usually linked to the pancreas, liver and muscles. The key point, however, is that a biological connection does not mean bone health alone determines blood sugar levels.
Dr Raju Vaishya, a senior consultant orthopaedic and joint replacement surgeon at Indraprastha Apollo Hospitals in New Delhi, told The Indian Express that bone should be viewed as an endocrine organ, meaning it releases hormones that can affect other parts of the body. He pointed to osteocalcin, a protein made by bone-forming cells, as one of the most studied links between the skeleton and glucose metabolism. In experimental work, the undercarboxylated form of osteocalcin has been shown to influence pancreatic beta cells, insulin secretion and insulin sensitivity. Reviews indexed by ScienceDirect, PubMed and Wiley describe the same broad pattern in animals: bone-derived osteocalcin appears to support insulin production and glucose handling, although its precise role in humans is still not settled.
The relationship also appears to run in the other direction. Dr Vaishya said people with type 2 diabetes face a higher risk of fragility fractures even when bone density looks normal or high, suggesting that bone quality may be impaired in ways that are not captured by standard scans. He added that insulin resistance, long-term high blood sugar, inflammation and advanced glycation end-products may all weaken bone structure and repair. Reviews and research articles from PubMed, The Journal of Clinical Investigation and Nature support the idea of a two-way conversation between bone and metabolism, with mouse studies showing that changes inside osteoblasts can alter osteocalcin levels and affect glucose homeostasis. But these studies also underline a major caveat: much of the evidence is strongest in animals, and human findings remain more uncertain.
For people trying to support both bone and metabolic health, the practical advice is familiar rather than experimental. Dr Vaishya said resistance training and weight-bearing exercise can help preserve muscle, improve insulin sensitivity and provide the loading needed to strengthen bone. Adequate protein, enough calcium and vitamin D, a healthy body weight and good glucose control also matter, while smoking, excess alcohol and fall risk should be addressed. He cautioned that protein needs should be individualised, particularly for people with kidney disease. The broader message from the research is cautious but important: bone and glucose metabolism are linked, yet that connection is not a licence to treat bone-targeted changes as proven diabetes therapy. For now, the evidence supports looking after both systems together, rather than assuming one will automatically fix the other.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
